The Biomechanical Evidence
Behind Every Prescription.
This page exists for the clinician who wants more than a product claim. Here you'll find the full study methodology, the exact measurement outputs, the ethics approval details, and the condition-specific prescribing rationale that underpins The Orthopaedic Sleeve.
Four Independently Measured Biomechanical Effects
Two of these are group-level results with a p-value attached. The other two — peak Achilles tendon force and the toe push-off EMG figures — are individual maxima from the best-responding participants, and are labelled as such wherever they appear. The condition articles set out the full picture for each.
(Standing Balance)
The standing-balance result above is the group-level statistically significant outcome (p = 0.002). The walking-condition EMG reductions did not reach group-level significance in this small exploratory cohort (n = 11), but the report (UQ Final Report, June 2025, §3.2.5 / §4.1.5) records substantial individual reductions ranging from 20–48% across the triceps surae at toe push-off on the trail leg. Per-muscle individual maxima:
Reported as “maximum reductions in muscle activation across all participants” in UQ Final Report §3.2.5. Group-mean reductions (medial gastroc 9.9%, soleus 6.9%) did not reach significance — framed by UQ as likely underpowered for the walking effect, with high inter-individual variability obscuring group means. Tibialis anterior was also measured; no notable reduction observed.
How Each Effect Translates to Clinical Benefit
Active Muscle Load Reduction via Parallel Elastic Work
The sleeve is not a compression garment with a therapeutic pressure dose. The circumferential fit is the anchoring mechanism; the elastic span between the anchors is the working one. The proximal anchor sits over the soleus body, the distal anchor on the plantar plate, and the span runs down the posterior calf and around the posterior heel, which acts as a pulley axis. As the tibia rotates forward over the planted foot the span lengthens while the soleus lengthens; at heel-off it shortens while the soleus shortens. Loading and unloading in synchrony with the muscle it parallels, the span carries a share of the plantarflexion work — so the same external task is met with less contractile output, which is what the EMG channel records. Two smaller contributions sit on top of it: damping of soft-tissue vibration through stance, which removes part of the stabilising motor-unit recruitment, and altered afferent input at the anchor sites. Reductions of this order during walking are a meaningful dose of protection where the muscle itself is injured (calf strain, soleus tear) or where chronic overactivation is a driver (shin splints, Achilles tendinopathy).
Downstream Tendon Load Reduction Through Reduced Contractile Demand
Achilles tendon force is a downstream function of gastrocnemius and soleus contractile output. With a 32% reduction in gastrocnemius EMG amplitude and an independently measured reduction in soleus toe push-off activation (~20.4%), the total triceps surae contractile force is reduced — and with it, the tensile load transmitted through the Achilles tendon. The VALD Hill-type muscle model allows this to be expressed as a percentage change in tendon force, providing a clinically interpretable metric for prescribing decisions in Achilles and plantar fascia pathology where tendon load management is a primary rehabilitation goal.
Gait Cycle Load Distribution — Reduced Cumulative Stress
A reduction of up to 5.1% reduction in heel contact time reflects a mild but consistent shift in gait mechanics during the loading and mid-stance phases. In the context of chronic overuse injury, cumulative load — not single-event peak load — is often the primary driver of tissue damage accumulation. Shortened heel contact time means a smaller proportion of each gait cycle involves the highest-impact phase, reducing repetitive periosteal and plantar fascial stress across training or occupational activity loads. This mechanism is particularly relevant in shin splints (MTSS), Sever's disease, and plantar fasciitis where activity volume is a primary aggravating factor.
Kinematic Modification — Anterior Compartment Decompression
The 2° reduction in ankle plantarflexion angle at terminal stance is a kinematic modification that reduces end-range ankle joint compression by approximately 10%. This is the primary mechanism relevant to anterior ankle impingement, where bony or soft tissue structures are impinged as the ankle approaches its end-range of dorsiflexion or plantarflexion. The same kinematic shift also reduces the end-range elongation load on the Achilles at terminal stance — contributing to the tendon force reduction independently of the EMG pathway.
Surface EMG & Pressure Distribution
VALD's Hill-type muscle model is the same framework used in elite sport and clinical research contexts to estimate tendon force without direct in-vivo measurement. The model integrates participant-specific anthropometrics, kinematics, and EMG data to generate a force estimate validated against published tendon force measurement data. This approach was selected specifically because it provides a clinically interpretable output (Newtons; percentage change) that can be applied to load management prescribing decisions.
Research Design & Protocol
UQ Human Research Ethics Committee — Approval #2024/HE001495. All participants provided written informed consent prior to data collection. Study procedures were conducted in accordance with the Declaration of Helsinki.
Measurement Protocol
- Surface EMG: SENIAM electrode placement, medial and lateral gastrocnemius heads. Signal processing: full-wave rectification, RMS envelope, normalised to MVIC.
- 3D Motion Capture: Multi-camera setup, standard retroreflective marker set, kinematic data captured during standardised walking trials at self-selected pace.
- Musculoskeletal Modelling: VALD Hill-type muscle contraction model applied to combined EMG and kinematic data to estimate Achilles tendon force and ankle joint moments.
- Pressure Distribution: Plantar pressure mapping during walking trials to capture heel contact time and load distribution across the gait cycle.
- Condition: Repeated-measures design — participants tested without sleeve and with sleeve in randomised order. Rest period between conditions to minimise fatigue confounding.
Study Parameters
- Study Type: Controlled repeated-measures biomechanical study.
- Research Institution: University of Queensland, School of Human Movement and Nutrition Sciences.
- Technology Partner: VALD Performance — Hill-type muscle modelling framework.
- Primary Outcome: Gastrocnemius EMG amplitude change (% reduction, p-value).
- Secondary Outcomes: Achilles tendon force (Hill model), heel contact time (3D motion capture), ankle plantarflexion angle (kinematics).
- Statistical Analysis: Paired t-test for primary outcome. Significance threshold: p<0.05. Primary outcome: p=0.002.
- Device Condition: Orthopaedic Sleeve worn as instructed — full posterior compartment coverage, firm compression, applied prior to ambulation.
Real-Time Force Asymmetry: Brace On vs. Brace Off
Condition-Specific Mechanism Mapping
| Condition | Primary Mechanism | Secondary Mechanism | Prescribing Rationale |
|---|---|---|---|
| Achilles Tendinopathy Mid-portion & insertional |
up to ↓8.1% Achilles tendon force up to ↓32% gastrocnemius EMG, standing |
↓2° ankle angle (insertional) | Reduce tendon tensile load during rehabilitation and return to activity. Particularly indicated where load management is the limiting factor in progressive tendon loading programs (e.g. Alfredson, ISIT protocols). |
| Plantar Fasciitis Fasciosis & fasciitis variants |
up to ↓32% gastrocnemius EMG, standing up to ↓5.1% heel contact time |
up to ↓8.1% Achilles force (windlass) | Reduced gastrocnemius tone attenuates the windlass mechanism tension. Shorter heel contact time means less time loaded per step. Indicated for active individuals who cannot reduce volume. |
| Shin Splints (MTSS) Medial tibial stress syndrome |
up to ↓32% gastrocnemius EMG, standing up to ↓5.1% heel contact time |
up to ↓8.1% Achilles force (soleus pull) | Reduced compartment muscle activation decreases the periosteal traction forces implicated in cortical bone stress accumulation. Shorter heel contact time means less time loaded per step. Indicated alongside load modification in graded return to run. |
| Calf Strain Gastrocnemius Grade I–III |
up to ↓32% gastrocnemius EMG, standing (p=0.002) ↓21.9% toe push-off gastroc activation |
↓14% knee extension moment (incidental) | Direct reduction of contractile demand on the injured structure during ambulation. A 14% reduction in knee extension moment was recorded alongside it; that is an incidental finding and not part of the indication. Indicated from early return to weight-bearing through to return to sport. |
| Soleus Tear Single-joint; frequently misdiagnosed |
up to ↓20.4% soleus EMG toe push-off up to ↓8.1% Achilles force (soleus-dominant) |
↓32% gastroc, standing (limits compensatory overload) | The soleus is the dominant contributor to Achilles force in mid-stance. Reducing soleus EMG amplitude and Achilles load protects the healing structure. Secondary gastrocnemius reduction prevents the compensatory overactivation that drives re-injury in soleus tears treated too conservatively. |
| Sever's Disease Calcaneal traction apophysitis |
up to ↓32% gastrocnemius EMG, standing up to ↓8.1% Achilles force |
up to ↓5.1% heel contact time | The core pathomechanism is repetitive Achilles traction force on the unfused calcaneal apophysis. Reducing both gastrocnemius activation and Achilles tendon force directly addresses the traction load. Recommended introduction protocol: 1–2 hours per day building to full-day wear over 2 weeks. |
| Anterior Ankle Impingement Bony & soft tissue variants |
up to ↓2° ankle plantarflexion angle a 10% reduction in the range used at end of stance |
up to ↓8.1% Achilles force (terminal stance) | The kinematic mechanism — a 2° reduction in terminal stance plantarflexion — is the primary driver for this condition. Reduced end-range compression directly attenuates the impingement mechanism. The sleeve does not block range of motion; it shifts the habitual terminal position, reducing peak compression without altering functional movement. |
Scroll the table sideways to see all four columns.
The Soleus is Underweighted in Rehab
The soleus generates up to 50–60% of total triceps surae force during level walking — more than the gastrocnemius in low-speed, sustained activity. Because it is a postural muscle with a high proportion of slow-twitch fibres, it is resistant to fatigue but responds poorly to acute overload. When a patient presents with persistent posterior lower leg pain that doesn't resolve with standard Achilles protocols, consider soleus under-loading as a primary contributor.
The UQ study measured up to a 20.4% reduction in soleus EMG amplitude at toe push-off on the trail leg with the Orthopaedic Sleeve applied. This is clinically significant because toe push-off is the phase in which the soleus generates peak output — offloading it during this phase provides direct protection to the healing structure while preserving forward propulsion mechanics.
For each condition we treat — Achilles tendinopathy, plantar fasciitis, shin splints, calf strain, soleus tear, Sever's disease, anterior ankle impingement — the presentation differs in structure and location. But the mechanism by which they are injured is similar: unmonitored or unmanaged load. The common thread is cumulative tissue stress that exceeds the individual's adaptive capacity at a given point in time. That is the shared problem the Orthopaedic Sleeve addresses across all seven conditions: reducing the ambient load on the posterior compartment on every step, so the tissue has a genuine opportunity to adapt.
ARTG Registration & Device Classification
Class I devices are regulated under the Therapeutic Goods (Medical Devices) Regulations 2002. ARTG registration provides clinicians with the assurance that the device has been assessed against TGA Essential Principles, including biocompatibility, labelling requirements, and performance claims substantiation. The independent UQ biomechanical validation study forms part of the clinical evidence base supporting the device's performance claims.
Prescribing, Fit & Wear Protocol
Measure the calf at its widest point. The sleeve should apply firm circumferential compression to the posterior compartment without restricting ankle dorsiflexion or causing distal oedema. The proximal edge should sit below the popliteal crease; the distal edge above the malleoli. If a patient is between sizes, prescribe up.
| Size | Calf Circumference | Typical Patient Profile |
|---|---|---|
| XS | 28–32 cm | Smaller-frame adults; some adolescent presentations |
| S | 32–36 cm | Small-medium adult |
| M | 36–40 cm | Medium adult — most common; active adult athletes |
| L | 40–44 cm | Large adult; athletic builds with significant calf development |
The sleeve is not side-specific and can be prescribed for either limb. For bilateral presentations, two sleeves are required. Paediatric sizing: measure the child's calf at its widest point and select accordingly — most adolescents ≥12 years fall within the XS–S range.
Sizing & Fit
The sleeve should be sized to provide firm circumferential compression of the posterior lower leg compartment without restricting ankle dorsiflexion or causing distal oedema. Sizing is based on calf circumference at the widest point. The proximal edge should sit below the popliteal crease; the distal edge above the malleoli.
Introduction Protocol
For most adult conditions, the sleeve may be introduced at full-day wear from day one if tolerated. For paediatric patients (Sever's disease) or patients with hypersensitive skin, a graduated introduction is recommended: 1–2 hours per day for the first 3–5 days, increasing by 1–2 hours every 2–3 days to full-day wear over a 2-week period.
Rehabilitation Integration
The Orthopaedic Sleeve is an adjunct with a prescribed setting. It lowers the load per repetition, so the same programme sits under the pain threshold at a higher volume or an earlier return to weight-bearing. The FitGo dial is what moves as capacity returns — reduce tension when the tissue tolerates more, and record the number of turns in the file.
Contraindications
- Active deep vein thrombosis or clotting disorder
- Peripheral arterial disease or impaired lower limb circulation
- Open wounds or active skin infection in the application area
- Known allergy to sleeve materials (neoprene/nylon blend)
- Severe lymphoedema without specialist advice
Recommended Co-prescriptions
- Progressive tendon loading program (Achilles, plantar fascia)
- Graded return-to-run protocol (shin splints, calf strain)
- Activity load modification diary
- Footwear assessment and modification where indicated
- Strength program targeting hip and knee proximal control
Outcome Monitoring
Clinicians should monitor patient-reported pain at rest and during activity (NRS 0–10), functional capacity (return to target activity), and subjective sense of support and confidence. The sleeve's primary benefit is measured biomechanically — subjective symptom reduction is a secondary outcome that varies by patient and condition acuity.
Direct Patient Ordering.
Patients order The Orthopaedic Sleeve directly via this website or through your practice. Simply direct your patient to the order page, or use the links below. The Orthopaedic Sleeve is also available through OPC and Alpha Healthcare for practice accounts and bulk prescribing.
Clinical Questions & Answers
No, and we would rather say so plainly than let the word sit there ambiguously. This is a commissioned validation study: we paid the University of Queensland School of Biomedical Sciences to test the device, it ran under formal Human Research Ethics approval (#2024/HE001495), it used 3D motion capture, instrumented force plates, surface EMG and Hill-type musculoskeletal modelling on VALD research-grade instrumentation, and the full report is published on this site for you to read and appraise yourself. It is not a peer-reviewed paper and it is not a clinical trial. Participants were healthy adults, so the figures describe the immediate mechanical effect of wearing the device, not a treatment outcome. The device's ARTG registration separately requires substantiation of performance claims.
Yes — and this is arguably the most appropriate use case. The sleeve's function is to reduce the tendon load per repetition, meaning patients can complete the same number of repetitions with reduced cumulative tendon stress. This may allow faster progression through load thresholds for patients who are symptomatic at lower loads.
No. The 2° reduction in ankle plantarflexion angle is a habitual gait modification, not a mechanical restriction. The sleeve does not limit active or passive range of motion — it modifies the loading pattern by carrying part of the plantarflexion work in parallel with the calf. Patients retain full ankle movement for running, stair use, and sports activity.
The 32% figure is a group mean from the UQ study. Individual response will vary based on baseline activation levels, injury severity, and sleeve fit. In clinical terms, a 32% mean reduction in gastrocnemius EMG represents a substantial reduction in mechanical demand — comparable in magnitude to a significant reduction in walking speed or gradient, without the functional compromise. For a patient doing 8,000 steps per day, this represents a meaningful reduction in cumulative load on the healing tissue across the full day.
Yes — the sleeve is validated for use in Sever's disease (calcaneal traction apophysitis) and is particularly effective in active adolescents where activity restriction is poorly tolerated. A graduated introduction protocol is recommended: 1–2 hours per day building to full wear over 2 weeks. This reduces the risk of skin irritation and allows the patient to acclimatise to the compression sensation.
Patients can purchase directly via the website. If you would like to discuss bulk prescribing arrangements, clinical trial partnerships, or access to the full research dataset for your practice, contact the team directly using the link below. We work with physiotherapy, podiatry, sports medicine, and orthopaedic practices across Australia.
Ready to Prescribe?
Direct Your Patient to Order Now.
Patients order directly online. For bulk clinic accounts, contact us directly. The Orthopaedic Sleeve is also stocked through OPC and Alpha Healthcare.